GEICO Sues New York Pharmacies Over Alleged Fraud
The insurer seeks to recover millions in damages related to alleged overbilling for high-cost topical pain products.
Updated on Oct. 22, 2026 in Financial Crime
Live Poll
Do you trust that insurance companies are effectively preventing fraud in the auto insurance system?
GEICO has filed a federal lawsuit in the Eastern District of New York against four pharmacies for an alleged multi-million dollar billing fraud scheme. The insurer claims the defendants used unlicensed clinics to push unnecessary prescriptions for topical pain products.
Why it matters
The lawsuit underscores the insurer's effort to recoup funds from a broader scheme involving no-fault insurance billing. By targeting these pharmacies, the insurer aims to stop millions in pending payments linked to alleged deceptive billing practices.
GEICO filed the complaint in the US District Court for the Eastern District of New York on October 21, 2026. The case remains active as the insurer seeks to recover $4.02 million already paid and block $4.69 million in pending claims.
The players
GEICO
This is a major American auto insurance company that provides coverage to millions of policyholders across the United States.
Liberty Mutual
This is a global insurance provider that previously engaged in litigation against the same pharmacy defendants in 2025.
The details
The lawsuit alleges that Medline Plus Pharmacy, 135 Jericho Pharmacy, Foremost Pharmacy, and Wellness Worx Pharmacy inflated costs for lidocaine and diclofenac, with some units priced as high as $2,149.15. These pharmacies reportedly shared owners and billing companies to hide their activities, while 95% of patients lived outside the operating county.
Timeline
The alleged fraud scheme began in late 2021.
Four people were involved in a specific car accident on September 15, 2024.
Liberty Mutual filed a similar lawsuit against the same defendants in 2025.
GEICO filed the federal complaint on October 21, 2026.
Legal Context
GEICO's action follows the pattern set by the 2025 Liberty Mutual lawsuit against the same four pharmacies, extending the legal pressure on these entities. These filings reflect broader efforts in the state to prosecute fraud within the no-fault auto insurance system.
While this litigation primarily concerns corporate insurance billing, fraud schemes in the no-fault system often lead to higher premium costs for local drivers. The legal scrutiny of these pharmacies may result in stricter oversight of prescription billing practices in the area.
The takeaway
Insurance fraud involving no-fault claims remains a high-stakes issue that impacts the stability of auto insurance rates. Policyholders should remain vigilant by reviewing their medical billing statements for accuracy and reporting suspicious prescription charges.
Further reading
Learn more about local investigations into fraud at New York Financial Crime.
Source note: This article includes information reported by Insurance Business.
Live Poll
Do you trust that insurance companies are effectively preventing fraud in the auto insurance system?
